Arbutus Biopharma Corporation (ABUS) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 179.13M | 1.05M | 529K | 10.74M | 1.76M | 1.57M | 1.34M | 1.73M | 1.53M | 2.15M | 4.66M | 4.65M | 6.69M | 6.25M | 5.95M | 14.24M | 12.58M | 3.21M | 3.34M | 2.33M |
| Revenue Growth % | 10054.54% | -33.23% | -60.49% | 522.19% | 15.14% | -26.62% | -71.25% | -62.89% | -77.09% | -65.65% | -21.74% | -67.34% | -46.85% | 94.79% | 78.2% | 511.46% | 495.41% | 34.37% | 119.3% | 53.83% |
| Cost of Goods Sold | 11K | 11K | 11K | 0 | 8.96M | 8.81M | 0 | 0 | 0 | 17.56M | 0 | 0 | 0 | 22.95M | 0 | 0 | 0 | 19.21M | 0 | 15.8M |
| COGS % of Revenue | 0.01% | 1.05% | 2.08% | - | 507.88% | 559.72% | - | - | - | 818.83% | - | - | - | 367.48% | - | - | - | 599.25% | - | 678.36% |
| Gross Profit | 179.12M | 1.04M | 518K | 10.74M | -7.2M | -7.24M | 1.34M | 1.73M | 1.53M | -15.42M | 4.66M | 4.65M | 6.69M | -16.7M | 5.95M | 14.24M | 12.58M | -16.01M | 3.34M | -13.47M |
| Gross Margin % | 99.99% | 98.95% | 97.92% | 100% | -407.88% | -459.72% | 100% | 100% | 100% | -718.83% | 100% | 100% | 100% | -267.48% | 100% | 100% | 100% | -499.25% | 100% | -578.36% |
| Gross Profit Growth % | 2589.44% | 114.37% | -61.31% | 522.19% | -569.65% | 53.07% | -71.25% | -62.89% | -77.09% | 7.69% | -21.74% | -67.34% | -46.85% | -4.36% | 78.2% | 205.72% | 207.82% | -14.28% | 131.68% | -50.49% |
| Operating Expenses | 10M | 8.68M | 8.81M | 9.25M | 27.46M | 6.7M | 22.78M | 23.31M | 20.89M | 5.33M | 26.22M | 23.04M | 24.1M | 5.86M | 23.76M | 28.35M | 23.55M | 4.79M | 21.75M | 5.17M |
| OpEx % of Revenue | 5.58% | 826.26% | 1665.6% | 86.14% | 1556.86% | 425.48% | 1701.19% | 1350.46% | 1363.9% | 248.39% | 562.82% | 495.29% | 360.4% | 93.8% | 399.24% | 199.07% | 187.23% | 149.41% | 651.14% | 222.07% |
| Selling, General & Admin | 5.88M | 3.7M | 3.03M | 3.33M | 5.83M | 8.43M | 4.54M | 7.55M | 5.31M | 5.1M | 5.84M | 5.98M | 5.55M | 4.25M | 3.49M | 5.2M | 4.89M | 4.6M | 4.18M | 4.48M |
| SG&A % of Revenue | 3.28% | 352.05% | 573.35% | 30.99% | 330.61% | 535.71% | 338.83% | 437.25% | 346.74% | 237.81% | 125.42% | 128.57% | 83.03% | 68.04% | 58.69% | 36.51% | 38.88% | 143.39% | 125.24% | 192.27% |
| Research & Development | 4.12M | 5.01M | 5.78M | 5.5M | 8.96M | 8.81M | 14.27M | 15.55M | 15.4M | 17.56M | 20.17M | 17.69M | 18.27M | 22.95M | 20.05M | 22.94M | 18.46M | 19.21M | 16.71M | 15.8M |
| R&D % of Revenue | 2.3% | 476.31% | 1092.25% | 51.2% | 507.88% | 559.72% | 1065.94% | 900.98% | 1005.42% | 818.83% | 433% | 380.39% | 273.29% | 367.48% | 336.95% | 161.1% | 146.75% | 599.25% | 500.27% | 678.36% |
| Other Operating Expenses | 0 | -22K | 0 | 425K | 1000K | -1000K | 1000K | 211K | 180K | -1000K | 205K | -636K | 273K | -1000K | 215K | 208K | 201K | -1000K | 856K | -1000K |
| Operating Income | 169.12M | -7.64M | -8.29M | 1.49M | -34.66M | -13.93M | -21.44M | -21.58M | -19.36M | -20.75M | -21.56M | -18.39M | -17.41M | -22.56M | -17.81M | -14.11M | -10.97M | -20.8M | -18.41M | -18.64M |
| Operating Margin % | 94.41% | -727.31% | -1567.67% | 13.86% | -1964.74% | -885.2% | -1601.19% | -1250.46% | -1263.9% | -967.23% | -462.82% | -395.29% | -260.4% | -361.28% | -299.24% | -99.07% | -87.23% | -648.66% | -551.14% | -800.43% |
| Operating Income Growth % | 587.96% | 45.14% | 61.32% | 106.89% | -78.99% | 32.84% | 0.55% | -17.39% | -11.2% | 8.04% | -21.04% | -30.31% | -58.68% | -8.49% | 3.24% | 24.32% | 29.99% | -27.57% | -20.97% | -41.86% |
| EBITDA | 169.13M | -7.63M | -8.28M | 1.5M | -34.33M | -13.6M | -21.1M | -21.23M | -19.01M | -20.39M | -21.19M | -18.04M | -17.08M | -22.25M | -17.47M | -13.73M | -10.58M | -20.37M | -17.96M | -18.21M |
| EBITDA Margin % | 94.42% | -726.26% | -1565.6% | 13.96% | -1945.86% | -864.04% | -1576.1% | -1229.84% | -1240.73% | -950.49% | -454.89% | -387.94% | -255.41% | -356.37% | -293.48% | -96.38% | -84.1% | -635.34% | -537.75% | -781.71% |
| EBITDA Growth % | 592.73% | 43.88% | 60.76% | 107.06% | -80.58% | 33.29% | 0.4% | -17.65% | -11.29% | 8.39% | -21.3% | -31.45% | -61.43% | -9.26% | 2.74% | 24.61% | 30.55% | -28.8% | -21.96% | -44.03% |
| D&A (Non-Cash Add-back) | 11K | 11K | 11K | 11K | 333K | 333K | 336K | 356K | 355K | 359K | 369K | 342K | 334K | 307K | 343K | 383K | 394K | 427K | 447K | 436K |
| EBIT | 169.12M | -7.64M | -7.72M | 2.55M | -24.5M | -15.67M | -19.69M | -19.76M | -17.83M | -20.52M | -20.06M | -16.92M | -16.14M | -20.95M | -17.14M | -13.71M | -10.81M | -20.6M | -18.4M | -17.95M |
| Net Interest Income | 798K | 859K | 929K | 1.01M | 1.17M | 1.43M | 1.72M | 1.79M | 1.5M | 1.42M | 1.45M | 1.29M | 1.07M | 634K | 265K | -86K | -347K | -530K | -735K | -732K |
| Interest Income | 815K | 877K | 952K | 1.04M | 1.2M | 1.46M | 1.75M | 1.83M | 1.54M | 1.47M | 1.49M | 1.46M | 1.27M | 943K | 694K | 396K | 159K | 30K | 27K | 31K |
| Interest Expense | 17K | 18K | 23K | 28K | 28K | 30K | 29K | 34K | 44K | 44K | 46K | 171K | 198K | 309K | 429K | 482K | 506K | 560K | 762K | 763K |
| Other Income/Expense | 578K | 3.89M | 551K | 1.03M | 10.13M | 1.4M | 1.72M | 1.79M | 1.49M | 1.44M | 1.45M | 1.29M | 1.07M | 630K | 244K | -83K | -347K | -525K | -750K | -745K |
| Pretax Income | 169.69M | -3.76M | -7.74M | 2.52M | -24.53M | -12.53M | -19.72M | -19.8M | -17.88M | -19.31M | -20.1M | -17.09M | -16.34M | -21.93M | -17.57M | -14.19M | -11.32M | -21.32M | -19.16M | -19.39M |
| Pretax Margin % | 94.73% | -357.37% | -1463.52% | 23.49% | -1390.36% | -796.19% | -1472.52% | -1146.93% | -1166.78% | -900.33% | -431.6% | -367.53% | -244.34% | -351.19% | -295.14% | -99.66% | -89.98% | -665.03% | -573.59% | -832.42% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.44M | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -39.25% | 0% | 0% | 0% |
| Net Income | 169.69M | -3.76M | -7.74M | 2.52M | -24.53M | -12.53M | -19.72M | -19.8M | -17.88M | -19.31M | -20.1M | -17.09M | -16.34M | -21.93M | -17.57M | -14.19M | -15.77M | -21.32M | -19.16M | -19.39M |
| Net Margin % | 94.73% | -357.37% | -1463.52% | 23.49% | -1390.36% | -796.19% | -1472.52% | -1146.93% | -1166.78% | -900.33% | -431.6% | -367.53% | -244.34% | -351.19% | -295.14% | -99.66% | -125.31% | -665.03% | -573.59% | -832.42% |
| Net Income Growth % | 791.9% | 70.03% | 60.73% | 112.75% | -37.21% | 35.11% | 1.93% | -15.81% | -9.4% | 11.95% | -14.44% | -20.45% | -3.64% | -2.87% | 8.3% | 26.8% | 3.76% | -25.11% | -2.15% | -37.62% |
| Net Income (Continuing) | 169.69M | -3.76M | -7.74M | 2.52M | -24.53M | -12.53M | -19.72M | -19.8M | -17.88M | -19.31M | -20.1M | -17.09M | -16.34M | -21.93M | -17.57M | -14.19M | -15.77M | -21.32M | -19.16M | -19.39M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.87 | -0.02 | -0.04 | 0.01 | -0.13 | -0.07 | -0.10 | -0.11 | -0.10 | -0.11 | -0.12 | -0.10 | -0.10 | -0.15 | -0.11 | -0.10 | -0.11 | -0.21 | -0.19 | -0.20 |
| EPS Growth % | 769.23% | 71.11% | 60% | 111.91% | -30% | 38.64% | 16.67% | -10% | -4.49% | 26.67% | -9.09% | -4.17% | 13% | 28.57% | 42.11% | 52% | 38.89% | -16.67% | 20.83% | 0% |
| EPS (Basic) | 0.88 | -0.02 | -0.04 | 0.01 | -0.13 | -0.07 | -0.10 | -0.11 | -0.10 | -0.11 | -0.12 | -0.10 | -0.10 | -0.15 | -0.11 | -0.10 | -0.11 | -0.21 | -0.19 | -0.20 |
| Diluted Shares Outstanding | 195.21M | 191.6M | 191.78M | 192.4M | 190.71M | 189.96M | 189M | 188.04M | 175.63M | 168.44M | 167.51M | 166.06M | 161.64M | 154.42M | 151M | 148.75M | 148.43M | 101.29M | 101.29M | 96.87M |
| Basic Shares Outstanding | 193.77M | 191.6M | 191.78M | 191.55M | 190.71M | 185.61M | 189M | 188.04M | 175.63M | 168.44M | 167.51M | 166.06M | 161.64M | 154.42M | 151M | 148.75M | 143.32M | 101.29M | 101.02M | 96.87M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |